Nemluvio 30 MG
Ended Awarded
- Contract number
- 36C24525N1013
- Awardee
-
Galderma Laboratories, L.P. UEI MNX4XY6QXEL3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $46,697
Award facts
- Contract value 100% obligated
- $46,697.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
Galderma Laboratories, L.P. was awarded a delivery order valued at $46,697.40 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of NEMLUVIO 30 mg pharmaceutical product. The contract, awarded on September 19, 2025, with an ultimate completion date of September 23, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed through the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with performance occurring in Carrollton, Texas.
Galderma Laboratories, L.P., a foreign-owned pharmaceutical manufacturer specializing in injectable drugs, has established itself as a primary supplier of injectable pharmaceutical products to the VA healthcare system across multiple VISN regions. The company, registered in the System for Award Management since 2002 and headquartered in Dallas, Texas, has received consistent federal contract awards exclusively through the VA for specialized injectable medications. This delivery order aligns with the company's demonstrated focus on providing pharmaceutical supplies to Veterans Affairs facilities and represents its continued engagement in delivering critical medical products to the federal healthcare marketplace.
Quick answers
Who was awarded contract 36C24525N1013?
36C24525N1013 was awarded to Galderma Laboratories, L.P. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 19, 2025.
How much is contract 36C24525N1013 worth?
The government has obligated $46,697 on 36C24525N1013.
Is contract 36C24525N1013 an order under another contract?
Yes. 36C24525N1013 is a delivery order under V797D70255, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N1013 competed?
The extent of competition for 36C24525N1013 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award